A Study of SYS6043 in Platinum-Resistant, Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancers
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Platinum-resistant Ovarian Cancer
Related studies linked through entity extraction aliases.
An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in China
- Status
- RECRUITING
- Phase
- PHASE3
GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of MGC026 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Biomarker Screening Protocol for Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- N/A
REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Combination of SON-1010 (IL12-FHAB) and Atezolizumab in Patients With Platinum-resistant Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Oral Topotecan Combined With Anlotinib in Patients With Platinum-resistant Recurrent Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2